Use of iron chelator for the treatment of myocardial infarction

Details for Australian Patent Application No. 2008250041 (hide)

Owner Novartis AG

Inventors Glasspool, John

Agent Davies Collison Cave

Pub. Number AU-A-2008250041

PCT Pub. Number WO2008/138912

Priority 60/917,714 14.05.07 US

Filing date 12 May 2008

Wipo publication date 20 November 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/138912 Priority application(s): WO2008/138912

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008250047-Mono-hydrochloric salts of an inhibitor of histone deacetylase

2008250037-Delivery device